InMed Pharmaceuticals (INM) Net Cash Flow Growth (5y) (2024 - 2026)

InMed Pharmaceuticals (INM) Net Cash Flow Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.96 Bn	43.00 Bn	-
2	Teva Pharmaceutical Industries	43.23 Bn	39.58 Bn	2.15 Bn
3	Zoetis	31.76 Bn	30.08 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn
6	Viatris	18.69 Bn	17.81 Bn	1.46 Bn
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn
8	Elanco Animal Health	11.78 Bn	11.25 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-
10	InMed Pharmaceuticals	6.48 Mn	1.24 Mn	-

Download Data